{"id":957161,"date":"2026-05-01T08:33:52","date_gmt":"2026-05-01T12:33:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/"},"modified":"2026-05-01T08:33:52","modified_gmt":"2026-05-01T12:33:52","slug":"pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/","title":{"rendered":"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026"},"content":{"rendered":"

\nCompany to hold a conference call at 8:30 a.m. ET
\n<\/h2>\n
\n

DURHAM, N.C., May 01, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report first quarter 2026 financial results on Thursday, May 14, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern time.<\/p>\n

Details for the conference call can be found below:<\/p>\n\n\n\n\n\n\n
Date:\u00a0\u00a0\u00a0<\/td>\nThursday, May 14, 2026<\/td>\n<\/tr>\n
Time:\u00a0\u00a0\u00a0\u00a0\u00a0<\/td>\n8:30 a.m. Eastern Time<\/td>\n<\/tr>\n
Toll Free:\u00a0\u00a0<\/td>\n1-877-451-6152<\/td>\n<\/tr>\n
International:\u00a0\u00a0<\/td>\n1-201-389-0879<\/td>\n<\/tr>\n
Conf. ID:\u00a0<\/td>\n13760399<\/td>\n<\/tr>\n<\/table>\n

\n
Webcast: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1761761&tp_key=d31924f2e0<\/a><\/p>\n

\n About Pelthos Therapeutics<\/strong>
\n
Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products that address unmet patient needs. ZELSUVMI\u2122 (berdazimer) topical gel, 10.3%, the company\u2019s lead product, is the first and only prescription therapy approved for use at home by patients, parents, and caregivers to treat Molluscum contagiosum<\/em>. The company\u2019s portfolio of assets includes Xepi\u00ae (ozenoxacin) Cream, 1%, a topical treatment for impetigo, and Xeglyze\u00ae (abametapir), a topical treatment for head lice. More information is available at www.pelthos.com<\/a>. Follow Pelthos on LinkedIn<\/u><\/a> and X<\/u><\/a>.<\/p>\n

\n Contacts<\/strong>
\n
Investors:
LifeSci Advisors, LLC
Mike Moyer, Managing Director
mmoyer@lifesciadvisors.com<\/a><\/p>\n

Media:
KWM Communications
Kellie Walsh
pelthos@kwmcommunications.com<\/a>
<\/a>(914) 315-6072<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to hold a conference call at 8:30 a.m. ET DURHAM, N.C., May 01, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report first quarter 2026 financial results on Thursday, May 14, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern time. Details for the conference call can be found below: Date:\u00a0\u00a0\u00a0 Thursday, May 14, 2026 Time:\u00a0\u00a0\u00a0\u00a0\u00a0 8:30 a.m. Eastern Time Toll Free:\u00a0\u00a0 1-877-451-6152 International:\u00a0\u00a0 1-201-389-0879 Conf. ID:\u00a0 13760399 Webcast: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1761761&tp_key=d31924f2e0 About Pelthos Therapeutics Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious … <\/p>\n

Continue reading “Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-957161","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to hold a conference call at 8:30 a.m. ET DURHAM, N.C., May 01, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report first quarter 2026 financial results on Thursday, May 14, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern time. Details for the conference call can be found below: Date:\u00a0\u00a0\u00a0 Thursday, May 14, 2026 Time:\u00a0\u00a0\u00a0\u00a0\u00a0 8:30 a.m. Eastern Time Toll Free:\u00a0\u00a0 1-877-451-6152 International:\u00a0\u00a0 1-201-389-0879 Conf. ID:\u00a0 13760399 Webcast: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1761761&tp_key=d31924f2e0 About Pelthos Therapeutics Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious … Continue reading "Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-01T12:33:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026\",\"datePublished\":\"2026-05-01T12:33:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/\"},\"wordCount\":233,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/\",\"name\":\"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==\",\"datePublished\":\"2026-05-01T12:33:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/","og_locale":"en_US","og_type":"article","og_title":"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 - Market Newsdesk","og_description":"Company to hold a conference call at 8:30 a.m. ET DURHAM, N.C., May 01, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report first quarter 2026 financial results on Thursday, May 14, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern time. Details for the conference call can be found below: Date:\u00a0\u00a0\u00a0 Thursday, May 14, 2026 Time:\u00a0\u00a0\u00a0\u00a0\u00a0 8:30 a.m. Eastern Time Toll Free:\u00a0\u00a0 1-877-451-6152 International:\u00a0\u00a0 1-201-389-0879 Conf. ID:\u00a0 13760399 Webcast: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1761761&tp_key=d31924f2e0 About Pelthos Therapeutics Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious … Continue reading \"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-01T12:33:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026","datePublished":"2026-05-01T12:33:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/"},"wordCount":233,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/","name":"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==","datePublished":"2026-05-01T12:33:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTA4MSM3NTc3MzkxIzUwMDEyNjcxOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=957161"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957161\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=957161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=957161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=957161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}